Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.
Lingjuan Hong, Gennong Chen, Yongjun Liu, Yuanfang Cao, Xueting Li, Weijie Li et al. A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo. // Nature Biotechnology. – 2026. – DOI: 10.1038/s41587-026-03344-5. – URL: https://www.nature.com/articles/s41587-026-03344-5
Lingjuan Hong, Gennong Chen, Yongjun Liu, Yuanfang Cao, Xueting Li, Weijie Li, Yumu Pan, Huahe Wang, Gaomeng Ru, Siyu Yang, Ming Cheng, Tongtong Lv, Yunfan Zhu, Shan Huang, Xiaoxiao Nian, Hongling Ou, Chengkun Wang, Sean X. Gu, Monkol Lek, & Lupeng Ye (2026). A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo. Nature Biotechnology. https://doi.org/10.1038/s41587-026-03344-5
Lingjuan Hong, et al. “A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo.” Nature Biotechnology, 2026. doi:10.1038/s41587-026-03344-5.
@article{Hong2026,
title = {A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo},
author = {Hong, Lingjuan and Chen, Gennong and Liu, Yongjun and Cao, Yuanfang and Li, Xueting and Li, Weijie and Pan, Yumu and Wang, Huahe and Ru, Gaomeng and Yang, Siyu and Cheng, Ming and Lv, Tongtong and Zhu, Yunfan and Huang, Shan and Nian, Xiaoxiao and Ou, Hongling and Wang, Chengkun and Gu, Sean X. and Lek, Monkol and Ye, Lupeng},
journal = {Nature Biotechnology},
year = {2026},
doi = {10.1038/s41587-026-03344-5},
url = {https://www.nature.com/articles/s41587-026-03344-5}
}